Wird geladen...
Therapeutic targeting of 3’,5’-cyclic nucleotide phosphodiesterases: Inhibition and beyond
Phosphodiesterases (PDEs), enzymes that degrade 3’,5’-cyclic nucleotides, are being pursued as therapeutic targets for several diseases, including those affecting the nervous system, cardiovascular system, fertility, immunity, cancer, and metabolism. Clinical development programmes have focused excl...
Gespeichert in:
| Veröffentlicht in: | Nat Rev Drug Discov |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6773486/ https://ncbi.nlm.nih.gov/pubmed/31388135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41573-019-0033-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|